FDA Adverse Event Injury Summary report: N

PROLIFT PELVIC FLOOR REPAIR

MDR report key: 3163175 · Received June 11, 2013

Report

Report Number
2210968-2013-07025
Event Type
Injury
Date Received
June 11, 2013
Report Date
May 24, 2013
Manufacturer
ETHICON INC
Product Code
OTP
PMA / PMN Number
K071512
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT UNDERWENT MESH IMPLANTATION IN ORDER TO TREAT PELVIC ORGAN PROLAPSE. IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED PAIN, EROSION, INFECTION, URINARY/BOWEL PROBLEMS, RECURRENCE, BLEEDING, DYSPAREUNIA, VAGINAL SCARRING, AND OTHER OUTCOMES FOLLOWING THE PROCEDURE. (B)(4).

Additional Manufacturer Narrative · 1

IT WAS REPORTED BY AN ATTORNEY THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2008 AND MESH WAS IMPLANTED CONCURRENTLY WITH ANTERIOR AND POSTERIOR REPAIR, BILATERAL SACRAL SPINOUS FIXATION, PLACEMENT OF TWO TUNNELED SUBFASCIAL CATHETERS FOR ON-Q PUMP, INGUINAL HERNIA REPAIR AND ABDOMINOPLASTY DUE TO SUI, CYSTOCELE, AND RECTOCELE.

Additional Manufacturer Narrative · 1

(B)(4). NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A SURGICAL PROCEDURE ON (B)(6) 2008 AND A MESH AND BOSTON SCIENTIFIC ADVANTAGE WERE IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
263461 PROLIFT PELVIC FLOOR REPAIR MESH, SURGICAL, POLYMERIC OTP ETHICON INC NA 3089795

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention BOSTON SCIENTIFIC ADVANTAGE